A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)
Clinical trial NCT00855361 · COMPLETED
Trial details
- NCT number
- NCT00855361
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2011-12-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.